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study question: Is it possible to restore ovarian function and natural fertility following the cryopreservation and autotransplantation of
whole ovaries, complete with vascular pedicle, in adult females from a large monovulatory animal model species (i.e. sheep)?
summaryanswer: Full (100%) restoration of acute ovarian function and high rates of natural fertility (pregnancy rate 64%; live birth rate
29%), with multiple live births, were obtained following whole ovary cryopreservation and autotransplantation (WOCP&TP) of adult sheep
ovaries utilizing optimized cryopreservation and post-operative anti-coagulant regimes.
what is knownalready: Fertility preservation byWOCP&TP requires successful cryopreservation of both the ovary and its vascular
supply. Previous work has indicated detrimental effects ofWOCP&TP on the ovarian follicle population. Recent experiments suggest that these
deleterious effects can be attributed to an acute loss of vascular patency due to clot formation induced by damage to ovarian arterial endothelial
cells.
study design, size, duration: Study 1 (2010–2011;N ¼ 16) examined the effect of post-thaw perfusion of survival factors (angio-
genic, antioxidant, anti-apoptotic; n ¼ 7–8) and treatment with aspirin (pre-operative versus pre- and post-operative (n ¼ 7–9)) on the restor-
ation of ovarian function for 3 months afterWOCP&TP. Study 2 (2011–2012;N ¼ 16) examined the effect of cryoprotectant (CPA) perfusion
time (10 versus 60 min; n ¼ 16) and pre- and post-operative treatment with aspirin in combination with enoxaparine (Clexanew; n ¼ 8) or epti-
ﬁbatide (Integrilinw; n ¼ 8) on ovarian function and fertility 11–23 months after WOCP&TP.
participants/materials, setting, methods: Both studies utilized mature, parous, Greyface ewes aged 3–6 years and
weighing 50–75 kg. Restoration of ovarian function was monitored by bi-weekly blood sampling and display of behavioural oestrus. Blood
samples were assayed for gonadotrophins, progesterone, anti-Mu¨llerian Hormone and inhibin A. Fertility restoration in Study 2 was quantiﬁed
by pregnancy rate after a 3 month fertile mating period and was conﬁrmed by ultrasound, hormonal monitoring and live birth. Ovarian function
was assessed at sacriﬁce by ovarian appearance and vascular patency (Doppler ultrasound) and by follicular histology.
main results and the role of chance: In Study 1, survival factors were found to have no beneﬁt, but the inclusion of pre-
operative aspirin resulted in four ewes showing acute restoration of ovarian function within 3 weeks and a further six ewes showing partial
restoration. The addition of post-operative aspirin alone had no clear beneﬁt. In Study 2, combination of aspirin with additional post-operative
anti-coagulants resulted in total acute restoration of ovarian function in 14/14 ewes within 3 weeks of WOCP&TP, with 9/14 ewes becoming
pregnant and 4/14 giving birth to a total of seven normal lambs. There was no difference between anti-coagulants in terms of restoration of re-
productive function and fertility. In contrast, the duration of CPA perfusion was highly signiﬁcant with a 60 min perfusion resulting in ovaries of
& The Author 2014. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse,
distribution, and reproduction in any medium, provided the original work is properly cited.
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normal appearance and function with high rates of primordial follicle survival (70%) and an abundant blood supply, whereas ovaries perfused for
10 minhadeither resorbed completely andwere vestigial (7/14)orweremarkedly smaller (P, 0.01). It is concluded thatboth thedegreeofCPA
penetration and the maintenance of post-operative vascular patency are critical determinants of the success of WOCP&TP.
limitations, reasons for caution: Before application of this technology to fertility preservation patients, it will be critical to op-
timize the CPA perfusion time for different sized human ovaries, determine the optimum period and level of anti-coagulant therapy, and conﬁrm
the normality of offspring derived from this procedure.
wider implications of the findings: This technology holds promise for the preservation of fertility in women. It could also po-
tentially be applied to the cryopreservation of other reproductive or even major organs (kidneys) where there are considerable difﬁculties in
storing donated tissue.
study funding/competing interest(s): Funding was received from the Medical Research Council, University of Nottingham.
The authors conﬁrm that they have no conﬂict of interest in relation to this work.
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Introduction
Premature ovarian failure (POF) affects 1–2% of women (Coulam et al.,
1986) and is due to a number of causes including genetic predisposition
and gonadotoxic treatment (Aubard et al., 2001; Kim et al., 2001). This
loss of ovarian function, in addition toprimary infertility and amenorrhoea,
can have far-reaching clinical and psychological effects such as failure to
develop secondary sexual characteristics, loss of self-conﬁdence, depres-
sion, and an increased risk of osteoporosis, and heart disease (Carr,
2003). The importance of POFand its impact on human health is increas-
ing due to the increased incidence of childhood cancer (Byrne et al.,
1992) and paradoxically the continued improvement in cancer patient
survival rates (Carr, 2003).
Ovarian tissue cryopreservation and autotransplantation (aTP) repre-
sents a potentially valuable technique in the preservation and restoration
of fertility (Picton et al., 2000). In instances when POF can be predicted,
ovarian tissue, and the oocytes within it, can be removed and protected
from damage or further deterioration in the frozen state and then
returned to resume development when the patient requires the restor-
ation of ovarian function (Campbell and Picton, 1999; Gosden et al.,
1999; Picton et al., 2000). Following pioneering proof of principle
studies which used sheep as a physiologically relevant model of ovarian
function for the human (Gosden et al., 1994; Baird et al., 1999), restor-
ation of fertility following cryopreservation and subsequent autografting
of small pieces of ovarian cortical tissue has been used to preserve and
restore the fertility of women, with reports of 25 live births following
both spontaneous ovulation and natural conception and the use of inter-
ventions such as IVF (Donnez et al., 2004, 2013;Demeestere et al., 2007;
Meirow et al., 2007; Andersen et al., 2008; Ernst et al., 2010; Silber,
2012). While this success is encouraging, the transplanted fragments of
ovarian cortex contain only a fraction of an individual’s ovarian reserve
and as such can only provide the recipient with a relatively brief fertile
window before the supply of oocytes contained within their graft is
depleted (Donnez et al., 2004, 2013; Demeestere et al., 2007; Meirow
et al., 2007; Andersen et al., 2008; Ernst et al., 2010; Silber, 2012). The
problem of graft longevity is exacerbated by freeze-thaw damage and
high rates of follicle loss due to ischaemia during revascularization of
the transplanted tissue (Gosden et al., 1994). These limitations mean
that cryopreservation and autografting of pieces of cortex appears to
be less effective as a means to restore the fertility of older patients in
whom follicle density is already low at the time of tissue preservation
and where it is associated with endocrine disturbance (Gosden et al.,
1994; Baird et al., 1999; Campbell et al., 2004). In marked contrast,
cryopreservation of the whole ovary, complete with vascular pedicle,
for later autotransplantation (WOCP&TP) provides an attractive
alternative strategy for fertility preservation as it involves restoration
of all of the primordial follicles within the ovary. Further, as aTP
requires vascular anastomosis rather than cortical revascularization,
this intervention should result in no marked diminution of ovarian
reserve due to ischaemia, thus preventing endocrine imbalance and
reducing the age constraints which limit the efﬁcacy of this fertility
preservation technology.
The concept of whole organ cryopreservation is attractive; however
attempts to freeze-store vital organs such as the heart, liver and kidney
have so far proved uniformly unsuccessful. The primary challenge with
whole organ cryopreservation, as distinct from the preservation of cell
suspensions or tissue fragments, is the crucial need to preserve an
intact vascular system to allow for subsequent organ revascularization
and function (Pegg, 2002, 2007). All methods of tissue cryopreservation
require the replacement of intra-cellularwaterwith penetrating cryopro-
tective agents (CPA) suchas dimethyl sulphoxide (DMSO).During organ
preservation this has usually been achieved by vascular perfusion. This
technique has the advantage of providing very short diffusion distances
for the CPA penetration, but conversely it has the potential to cause
microvascular damage (Pegg, 1972, 2002, 2007). Themechanismsof cel-
lular damage and the mode of action of CPAs are now well understood
and it is clear that the cellular injury and loss caused by the formation of
intra-cellular ice during cooling and warming can usually be avoided,
whereas the formation of ice in extra-cellular locations, and particularly
in blood vessels, can produce serious injury and prevent organ revascu-
larization (Rubinsky and Pegg, 1988; Pegg, 2002, 2007).
Faced with these constraints of organ cryopreservation, to date,
attempts to perform WOCP&TP in large animals have met with only
limited success.Despite apparently high ratesof post-thaw tissue viability
followingWOCP in both human (Bedaiwy et al., 2006; Jadoul et al., 2007;
Martinez-Madrid and Donnez, 2007) and sheep (Onions et al., 2008),
aTP of these frozen ovaries in both lambs (Revel et al., 2004; Arav
et al., 2005, 2010; Imhof et al., 2006) and adult animals (Bedaiwy et al.,
2003; Onions et al., 2008, 2009) have resulted in high rates of follicle
loss and organ failure resulting in low rates of restoration of ovarian
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function and fertility. The report of a live birth from a lamb which had
undergone WOCP&TP (Imhof et al., 2006), albeit 545 days after aTP,
and the fact that those animals that do show restoration of ovarian func-
tion continue to cycle for many years (Bedaiwy et al., 2008; Arav et al.,
2010) does, however, illustrate the promise of this intervention for res-
torationof fertility. Recent experiments inour laboratory suggest that the
deleterious effects on both the ovarian follicle population and surround-
ing ovarian tissue followingWOCP&TP can be attributed, at least in part,
to an acute loss of vascular patency that appears to be associated with
signiﬁcant changes in gene expression in arterial endothelial cells of
local factors associated with vascular tone, wound repair and/or
hypoxia (Onions et al., 2013). In this paper, we report that optimization
of CPA penetration during whole ovary perfusion and the use of
anti-thrombotic agents to prevent post-operative clot formation in the
ovarian vasculature results in a dramatic increase in the success rates
ofWOCP&TP in adult sheep, with the rapid restoration of ovarian func-
tion in all animals and good rates of natural fertility andmultiple live births
being achieved in adult animals.
Materials andMethods
All materials were purchased from Sigma Aldrich, Dorset, UK, unless other-
wise stated. All sutures were purchased from Ethicon, Edinburgh, UK.
Whole ovarian cryopreservation and
transplantation in vivo
Experimental animals
All animal procedures were carried out with approval from the UK Home
Ofﬁce and in accordance with the Animals (Scientiﬁc Procedures) Act
1986 following ethical review. Experimental animals were mature parous
Greyface (cross between Scottish Blackface and Bluefaced/Border Leicester
breeds) ewes 3–6 years old weighing 50–75 kg. Ewes were obtained from
commercial sources and subject to veterinary inspection prior to use.
Eweswere normally housed in group pens on deep straw bedding in a natur-
ally ventilated and lit barn and fed a maintenance diet of ad libitum hay sup-
plemented with 600 g/day concentrated sheep ration. At the time of
surgery, general anaesthesia was induced using sodium thiopenthal
(15 mg kg21) with animals intubated and kept under inhaled anaesthesia
with isoﬂuorane (2.5–3%). Post-operative analgesia and antibiotic cover
was provided in the form of a non-steroidal anti-inﬂammatory drug
(2.2 mg kg21; Finadyne, Shering Plough Animal Health, Herts, UK) and
broad spectrum antibiotic (3–4 ml animal21, Streptacare, Animal Care,
Ltd, York, UK) for 3–5 days after surgery. Prior to aTP, each ewe was
treated with a regime of progesterone and estradiol benzoate previously
shown to increase ovarian and uterine blood ﬂow (Brown and Mattner,
1984). This regime consisted of progestagen impregnated sponges (ﬂuges-
tone acetate; Chronogest CR, Intervet UK Ltd, Milton Keynes, UK)
implanted intravaginally for 10–11 days, with sponge withdrawal and estra-
diol benzoate injection (100 mg animal21) on the day before aTP.
Ovarian collection, perfusion and cryopreservation
Mid-ventral laparotomy was performed under general anaesthesia and the
ovary and 10–15 cm of the ovarian vascular pedicle was carefully dissected,
with side branch vessels being cauterized or tied off as appropriate, to a point
just proximal of the bifurcation of the utero-ovarian vein into its ovarian and
uterine branches. At this point, the vascular pedicle normally consists of just
one uterine vein and a less tortuous ovarian artery and these vessels were
ligated with a single suture (4/0 Mersilk), then excised and the ovary and
pedicle removed. With the aid of an operating microscope (OPMI 6 SFR
with Universal S2 stand microscope; Carl Zeiss mbH, Oberkochen,
Germany), the ovarian artery was cannulated using a 2.5F (0.75 mm OD)
intravenous cannulae (Sims Portex Limited, Kent, UK) in 2010 (Study 1) or
a 22G Leaderﬂex cannula with extension (0.7 mm × 20 cm, Vygon GmbH
& Co., Aachen, Germany) in 2011 (Study 2). The cannula was tied securely
in place using two 0 mersilk (Ethicon, Edinburgh, UK) ligatures. The ovary
and cannulated pedicle were then transferred to perfusion trays and sub-
jected to cryoperfusion and cryopreservation, as detailed previously
(Onions et al., 2009). Brieﬂy, the ovary was initially perfused, via the
cannula, with cold, sterile, heparinised (100 IU ml21) Ringer’s solution for
10 min at a rate of 1 ml min21 before being perfused with the cryopreserva-
tion media for either 10 (Study 2) or 60 min (Study 1 and 2) at a rate of
0.5 ml min21 using a syringe driven perfusion pump (Precidor Infors Ag
Basel; ChemLab Scientiﬁc Products Ltd, Hornchurch, UK) ﬁtted with a
50 ml syringe. All solutions were refrigerated before use and all perfusions
were carried out on ice. The cryopreservation media (CPA) was Leibovitz
L-15 media supplemented with 1.5 mol l21 DMSO, 0.1 mol l21 sucrose
and10%(v/v) heat inactivated fetal calf serum(FCS). Themediawasadjusted
to pH 7.3–7.4 and ﬁlter sterilized using a 0.22 nm syringe ﬁlter (Minisartw,
Sartorius biotech, Surrey, UK) prior to use.
With the aid of a Planer controlled rate freezer (Kryo 550-16; Planer plc,
Middlesex, UK) a slow-freezing cryopreservation protocol was utilized,
which involved cooling to 298C at 218C min21 before manual seeding
was carried out. The temperature was then reduced at 20.28C min21 to
2408C following which the temperature was lowered at an increased rate
of 2108C min21 to a ﬁnal temperature of 21408C. The cryogenic vials
were then plunged into and stored in liquid nitrogen for at least 4 weeks
prior to aTP.
Ovarian thawing
Each ovary was rapidly thawed in a 378Cwater bath as described previously
(Onions et al., 2008) and transferred to a laminar ﬂow hood. The ovary and
pedicle were placed in a perfusion tray and immersed in and perfused with
warmthawingmedia. Three thawingmediawereused, consisting of Leibovitz
L-15 media supplemented with 10% FCS and reducing concentrations of
DMSO (1 M, 0.5 M, 0 M). Sucrose was included only in the ﬁrst thawing
media at 0.1 M. All three thawing media (pH 7.3–7.4) were ﬁlter sterilized
prior to use and perfused warm (378C) through the ovary for 10 min at a
rate of 1 ml min21. The cannula was then eased from the ovarian artery
ready for reanastomosis.
Experimental designs
Study 1: effect of anti-thrombotic (aspirin) and survival factors on ovarian
function following WOCP&TP
This initial WOCP&TP experiment, conducted over 2010–2011, examined
the hypothesis that the deleterious effects ofWOCP&TP on the ovarian fol-
licle population and surrounding ovarian tissue could be attributed to an
acute loss of vascular patency associated with clot formation in the ovarian
arterial blood supply (Onions et al., 2013). Two strategies were tested in
order to minimize these vascular defects in a 2 × 2 factorial design utilizing
16 ewes in total: (i) the treatment of ewes with the anti-thrombotic aspirin
(300 mg/day per os), either pre-operatively just prior to induction of anaes-
thesia for aTP (n ¼ 9) or pre- and post-operatively for 5 days after surgery
(n ¼ 7); and (ii) the infusion of ‘survival factors’ (the anti-apoptotic factor:
sphingosine-1-phosphate, the antioxidant: vitamin E, and the vascular
factor: vascular endothelial growth factor) through the ovary and vascular
pedicle post-thaw, prior to aTP (n ¼ 7–8). Ewes were ﬁrst randomized to
survival factor treatment or not and then re-randomized to post-surgical
aspirin treatment or not so that experimental groups were balanced accord-
ing to number, animal age and weight. The slight imbalance in the ﬁnal design
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was due to one ewe not being operated on due to severemastitis and a tech-
nical error resulting in one ewe not receiving post-operative aspirin.
In this study, only one ovary was removed from each ewe for cryopreser-
vation, as described above, at the time of initial laparotomy, with the contra-
lateral ovary being left undisturbed for later collection to act as a time zero
control. Either the left or right ovary was removed for cryopreservation on
a random basis so groups were balanced. At least 4 weeks after cryopreser-
vation, frozen ovaries were thawed as described above and ewes were ran-
domized to either infusion with the ﬁnal equilibration wash of Leibovitz L-15
mediawith 10% FBS (TM3) alone (n ¼ 8) or TM3 further supplementedwith
vascular endothelial growth factor (VEGF 121; 10 ng/ml), sphingosine-1-
phosphate (S-1-P; 170 mM) and Vitamin E (0.6 mM; n ¼ 7) for one hour
prior to transplantation.
All ewes received 300 mg of dispersible aspirin dissolved in water given
orally immediately prior to induction of general anaesthesia for autotrans-
plant surgery. During transplant re-equilibration, a transplantation site was
prepared in the appropriate recipient ewe following a second laparotomy
under general anaesthesia. This was accomplished by dissection of the
ovarian vein and artery from the contralateral side so that freshly excised
patent vessels were available for end-to-end micro-anastomosis to the
ovarian artery and vein of the cryopreserved autotransplant, utilizing 10/0
and 8/0 Ethilon sutures respectively. The surgery was performed by a
highly experienced vascular surgeon (B.K.C.) with the aid of aZeiss operating
microscope. The fresh ovarian and vascular tissue from the contralateral
ovary was placed in Bouin’s ﬁxative for later histological analysis. All ewes
received 5000 IU of heparin (i.v.) immediately prior to removal of vascular
clamps to allow re-perfusion of blood through the transplant. Adequate
re-perfusion was achieved with all autotransplants and the autotransplanted
ovary and pediclewere attached to the uterine horn in as natural a position as
possible with 6/0 Prolene sutures. After careful checking that haemostasis
had been achieved, the abdominal wall was closed and the animal was
allowed to recover, with 7 of the animals receiving a further 300 mg of post-
operative aspirin daily for 7 days after the surgery. Commonly heat lamps
were used during the recovery period and the animals were observed
closely for signs of post-operative haemorrhage. The animals were kept in in-
dividual pens for around 7 days after the second surgery and were then
moved to group pens for endocrine and behavioural monitoring. This con-
sisted of collection of samples of jugular venous blood at 3–4 days intervals
for 3 months and the detection of behavioural oestrus by inclusion of 1–2
vasectomized rams within the ﬂock that were ﬁtted with a marking device
to record mating behaviour. At the end of this 3 month period, all ewes
were sacriﬁced for tissue collection.
Study 2: the effect of time of CPA perfusion and post-operative anti-thrombotic
therapy on restoration of ovarian function and fertility following WOCP&TP
On the basis of results obtained from Study 1 and subsequent in vitro studies,
this ﬁnal experiment was conducted over 2011–2012 and tested whether
either a 10 or 60 min CPA perfusion supported superior restoration of
ovarian function following WOCP&TP. This experiment involved a direct
within-animal comparison with one ovary in each ewe being perfused with
CPA for 10 min and the other being perfused for 60 min prior to WOCP
(see Fig. 1). Similarly, on the basis that vascular CPA toxicity would not be
limited by the shorter perfusion times, the effect of an extended post-
operative regime of anti-thrombotic agents was tested in order to reduce
post-transplant ischaemia by preventing clot formation in the ovarian vascu-
lature inducedby cryo- and cyto-toxic damage to the arterial endothelial cells
(Onions et al., 2013). The two regimes tested, combined pre- and post-
Figure 1 Illustration of the experimental design utilized for Study 2 which was conducted over the breeding season of 2011–2012. This experiment
utilized 16 Greyface ewes who all underwent WOCP&TP. In addition to pre-operative Aspirin treatment and the intravenous injection of heparin prior
to autotransplant revascularization, these ewes were randomized to two post-operative anti-coagulant regimes (n ¼ 8) which involved the combination
of aspirin treatment with either the injectable low molecular weight heparin enoxaparin (Clexanew; Asp+LMWH) or the glycoprotein IIb/IIIa inhibitor
eptiﬁbatide (Integrilinw; Asp+Eptiﬁb). To further test the relative effectiveness of infusion of CPA for either 10 or 60 min prior to cryopreservation,
the sheep were re-randomized within animal to allocate either the left or right ovary of each ewe to either the 10 or 60 min perfusion groups. These
groups were balanced and great care was taken during the double autotransplantation procedure, which was performed at the same time, that there
was no bias due to differences in the post-thaw period prior to re-anastomosis, surgeon fatigue or level of anti-coagulants in the circulation at the time of auto-
transplant revascularization. Theactual experimental group sizes for analysiswere reduced to n ¼ 7due tooneanimal not receiving pre-operative aspirin treat-
ment andoneanimal notbeing able to receive adoubleovarianautotransplantdue todamage to theuterine arteryduring initial surgery. Statistical analysis of this
designwas simpliﬁedby the fact that bothanti-coagulant regimesprovedequallyeffective in restoringovarian function and fertilityand thesedatawere therefore
pooled to allow a paired analysis within animal of the effect of CPA perfusion time with n ¼ 14.
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operative aspirin treatment with either the injectable low molecular weight
heparin enoxaparin (Clexanew; Asp+LMWH(Hep)) or the glycoprotein
IIb/IIIa inhibitor eptiﬁbatide (Integrilinw; Asp+Eptiﬁb(Integ)). Due to con-
cerns over the ability of sheep to tolerate these drugs, the doses used
were relatively low and were well tolerated by the animals with no obvious
adverse effects and 100% post-operative survival.
This experiment utilized 16 ewes and these animals were randomized
according to animal number, age and weight to either of the post-operative
anti-coagulant regimes (n ¼ 8) and then re-randomized within animals to al-
location of left or right ovaries to either 10 or 60 min of CPA perfusion so
groups were balanced (n ¼ 8; see Fig. 1). However, actual experimental
group sizes were reduced to n ¼ 7 due to one animal not receiving pre-
operative aspirin treatment and one animal not being able to receive a
double ovarian autotransplant due to damage to the uterine artery during
initial surgery (Fig. 1).
Thus in Study 2 (2011–2012), both ovarieswere removed for cryopreser-
vation as described above, at initial laparotomy. The ﬁrst ovary removedwas
perfused with 30 ml of CPA over a 60 min period and the second ovary
removed was perfused with 5 ml of CPA over a 10 min period, before
both ovaries were cryopreserved in the same run of a Planer controlled
rate freezer as described above.
Both ovaries were returned in a single operation aminimum of onemonth
after cryopreservation. As in Study 1, in the 10–11 days prior to aTP, all
animals received a pretreatment with progesterone and estradiol benzoate
in order to boost uterine blood ﬂow (see above) and prior to induction of
general anaesthesia all ewes received 300 mg of dispersible aspirin dissolved
in water and given orally. The thawing of each ovary to be autotransplanted,
as described above, was carefully timed so that the ovary was taken from
liquid nitrogen 60–70 min prior to the estimated time of re-anastomosis.
Each ovarywas returned to its original position utilizing an end-to-sidemicro-
anastomosis of the ovarian artery to the appropriate uterine artery (10/0
Ethilon) and the ovarian vein to an appropriately sized uterine vein (8/0
Ethilon) by the same experienced surgeon (B.K.C.). The autotransplanted
ovary and pedicle were attached to the appropriate uterine horn in as
natural a position as possible with 6/0 Prolene sutures. As in Study 1, all
ewes received 5000 IU of heparin (i.v.) immediately prior to removal of vas-
cular clamps to allow re-perfusion of blood through the ﬁrst ovarian auto-
transplant. To make sure there was no experimental bias in terms of
thawing times, surgeon fatigue and circulating heparin levels, the left ovary
was thawed and autotransplanted ﬁrst and the right ovary thawed and
autotransplanted second. In this way an equal number of ovaries perfused
with CPA for 10 and 60 min were autotransplanted ﬁrst. Re-vascularization
of the autotransplant was achieved in all instances and there were no
post-operative complications.
In this study, as detailed above, the same regime of pre-operative and op-
erative aspirin and heparin treatment was applied as was utilized in Study 1,
but in addition post-operatively the animals received 300 mg of aspirin (per
os) in combination with either 20 mg injectable heparin (Enoxaparin sodium
2000 units s.c.; ClexanewRhone-Poulenc Rorer; n ¼ 8) or eptiﬁbatide (2 mg
ml21 i.v.; IntegrilinwGlaxo-Smith Kline; n ¼ 8) daily for 7 days after aTP. The
eptiﬁbatide was initially given at a dose of 10 mg/day for the initial 48 h after
surgery and then2 mg/day for the following5days.Due to concernsover the
ability of sheep to tolerate these drugs after major surgery, these doses of
enoxaparin (LMWH: 50%) and eptiﬁbatide (10%) were signiﬁcantly lower
than those recommended by the manufacturer for use in humans for treat-
ment of myocardial infarction (BNF, 2008).
From the time of aTP, all animals had samples of jugular venous blood col-
lected at 3–4 days intervals and in addition for detection of behavioural
oestrus ewes were run in a group with 1–2 entire rams which were ﬁtted
with amarkingdevice to recordmatingbehaviour.Theseeweswerealso sub-
jected to trans-abdominal ultrasound scanning for pregnancy detection at
15, 17 and 20 weeks post-aTP.
Tissue collection
Under terminal general anaesthesia, the reproductive tracts were visualized
following mid-ventral laparotomy and the size and appearance of the ovary(s),
uterus and vascular pedicle were noted and photographed. The presence of
adhesions was also recorded. Conventional and Power Doppler ultrasound
(15–7io transducer, iU22 xMATRIX Ultrasound System, Royal Phillips Elec-
tronics, Amsterdam, The Netherlands) was used to conﬁrm the presence or
absence of antral follicles and blood ﬂow through the ovary and these images
were stored for later analysis. The animalswere then sacriﬁced by an overdose
of sodiumpentobarbitoneand theovary completewithpedicle (if present)was
ﬁxed for later histological analysis. In Study 2, animals which had become
pregnant and carried lambs to term were not sacriﬁced until October 2013,
22 months after aTP.
Histological analyses
Theﬁxed tissue sampleswereprocessedusing an ascending seriesof alcohols
and cleared using xylene. The tissue samples were then parafﬁn wax embed-
ded for subsequent histological evaluation to quantify the follicle population
as previously described (Onions et al., 2013). Follicle count data were
expressed per unit volume of ovarian tissue and subject to square root trans-
formation prior to analysis by onewayANOVAor paired and unpaired t-test
as was appropriate.
Hormone analysis
Blood samples were centrifuged at 48C and 3000g for 15 min to obtain
plasma which was stored at 2208C until assay. FSH (Onions et al., 2009),
LH (Onions et al., 2009) and progesterone (Campbell et al., 1994) were
determined by radioimmunoassay as previously described apart from the
progesterone assay which utilized a different antibody (SAPU R7044X
(Campbell et al., 1998)).All assays had intra-assayand inter-assay coefﬁcients
of variation of ,10 and 15% respectively. In Study 1, hormone proﬁles
between individuals were too variable to meaningfully average but in
Study 2, it was possible to generate and analyse mean proﬁles, particularly
over the breeding season. The effect of post-operative type of anti-coagulant
therapyonhormoneproﬁle datawas thereforeanalysedusing repeatedmea-
sures ANOVA, with data being log transformed prior to statistical analysis.
Anti-Mu¨llerian hormone (AMH) levels were determined by a competitive
enzyme immunoassay kit (CSB-E12756h; Cusabio Biotech Co., Ltd, Hubei,
China) adapted forovine samples. Brieﬂy, 50 ml of either sampleor standards
were added to corresponding wells, followed by 50 ml of horseradish perox-
idase conjugate and 50 ml of anti-AMH antibody. After 60 min incubation at
378C, plates were washed three times, then substrate was added (100 ml)
and incubated in the dark for 15 min at 378C. The reaction was stopped
and visualized at a wavelength of 450 nm (with correction at 630 nm; Bench-
mark, Bio-Rad Laboratories, Hercules, CA, USA). AMH concentrations were
calculated from the corresponding standard curve using MicroplateManagerw
v5.2.1 software (Bio-RadLaboratories). The assay sensitivitywas0.38 ng ml21
with inter- and intra-assay coefﬁcients of variation of ,15%, respectively.
Inihibin A circulatory concentrations were measured using a modiﬁed
two-site immunoassay (ELISA) as previously reported (McNeilly et al.,
2002), using an inhibin bA subunit monoclonal antibody as the capture anti-
body (Groome et al., 1990) and anaC-speciﬁc biotinylatedmonoclonal anti-
body (Bleach et al., 2001). Assay sensitivity was 32 pg ml21, with 14.5 and
7.5% of inter- and intra-assay %CV, respectively.
Determinations of CPA penetration and
toxicity in vitro
CPA penetration and toxicity were determined by nuclear magnetic reson-
ance (NMR) and lactate dehydrogenase (LDH) assays.
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Sheep reproductive tracts were obtained from a local abattoir and the
ovaries, complete with vascular pedicle, were dissected and the ovarian ar-
teries cannulated as described above. Following cannulation, the ovary was
then ﬂushed with cold (0–48C) heparinized Ringer’s solution to remove
blood and to conﬁrm correct cannula placement. Ovaries were randomly
assigned to treatment groups consisting of different periods of exposure
during CPA infusion; 0 (control), 3, 10, 15, 30 and 60 min of perfusion.
The rate of CPA infusion utilizing a syringe driven pump was 0.5 ml/min.
Toquantify the relationship betweenCPApenetration andperfusion time,
duplicate samples of ovarian cortex, medulla and vascular pedicle were col-
lectedwith the aid of a biopsy punch (3 mm). Surfacemoisturewas removed
fromeachbiopsyusing ﬁlter paperand tissuewas immersed in 600 ml ofDeu-
terium oxide (D2O, 99.9%; Sigma, London, UK) in 1.7 ml Eppendorf tubes
with a cap. The tube was then covered with paraﬁlm and the cap secured.
The tubes were frozen and stored at 2208C until the time of NMR analysis
as previously described (Newton et al., 1998). At least three replicate runs
with two replicates per treatment per run were conducted for each deter-
mination (n ¼ 6).
To quantify the relationship between CPA perfusion time and tissue tox-
icity, following perfusion the ovaries and vascular pedicle were subjected to
slow freezing and thawing as described above. Tissue biopsies of ovarian
cortex, medulla and pedicle (n ¼ 6) were transferred into 24-well culture
dish containing 1 ml of warm (378C) culture media (M199 supplemented
with HEPES, antibiotics and anti-mycotics) and cultured overnight at 378C
with 5% CO2. The culture media was then aspirated and assayed for LDH
in triplicate (Cytotoxicity Detection Kit, Roche 11644793001; Burgess Hill,
UK). LDH data were log transformed and analysed by ANOVA with
Tukey’s post hoc test.
Results
Study1 (2010–2011): effectof anti-thrombotic
(aspirin) and survival factors on ovarian
function followingWOCP&TP
In comparison to previous WOCP&TP experiments in our laboratory
(Onions et al., 2009, 2013) in which 5000 IU heparin was routinely admi-
nistered just prior to transplant re-vascularization, the inclusion of 300 mg
of pre-operative aspirin in the anti-coagulant regime given to all ewes had
an unexpected, but markedly beneﬁcial effect on the restoration of
ovarian function following WOCP&TP. Of the 15 ewes, 10 showed
evidence of at least partial restoration of ovarian function (Table I).
Four of these animals had full ovarian function returned within 4–7
(5.4+0.9 mean+ SEM) weeks of aTP (Fig. 2) and all showed regular
oestrous cycles which were characterized by cyclic ﬂuctuations in pro-
gesterone, the display of oestrus behaviour at normal intervals (15–20
days) and a rapid decline in FSH and LH concentrations to normal
levels following aTP (Fig. 2A: LH not shown). The ovaries of these four
animals were of normal appearance and vascularity (Fig. 2B) and con-
tained morphologically normal well vascularized corpora lutea and
antral follicles (Fig. 2B and C). However, the population of primordial
and pre-antral follicles in the WOCP&TP animals which resumed oes-
trous cycles was estimated to be only around 20% of the normal
ovarian population present in untreated control animals (Table I).
The ﬁve animals which showed no evidence of restoration of ovarian
function following WOCP&TP had constantly high levels of FSH
(.10 ng/ml) and low levels of progesterone (,0.2 ng/ml) and their
ovaries and vascular pedicle had resorbed and were vestigial at the end
of the 3 month monitoring period (Table I).
The remaining six animals, which showed a partial restoration of
ovarian function, exhibited highly variable ﬂuctuations in FSH (Table I)
and progesterone levels (not shown) across the monitoring period and
the ovaries were markedly smaller (P, 0.01; Table I) with signiﬁcantly
fewer (P, 0.05)primordial andpre-antral follicles (Table I) thannormal-
ly cycling animals. As expected, the circulating levels of the ovarian
reservemarker, AMH,were found to be very low in animals with no res-
toration of ovarian function, but did not differ between animals with
partial and full restoration of ovarian cyclicity (Table I).
Contrary to expectations, however, neither inclusion of survival
factors in the ﬁnal re-equilibration perfusate used immediately prior to
aTP or continuation of aspirin treatment alone for 5 days after aTP
showed any evidence of having a beneﬁcial effect on the rate of restor-
ation of fertility following WOCP&TP. Thus, of the four animals which
displayed full acute restorationof ovarian function, only twohad received
survival factors and only two had received post-operative aspirin. Sim-
ilarly, of the six ewes which showed partial restoration of ovarian
function, only three had received survival factors and only two had
received post-operative aspirin. Examination of the possible effect of
.............................................................................................................................................................................................
Table I Summary of results fromWOCP1TP study conducted in 2010–2011 (Study 1) testing the effect of exposure of the
frozen ovary to survival factors post-thaw and the inclusion of aspirin in the anti-coagulation regime.
Characteristic No restoration Partial restoration Full restoration
Number animals 5 6 4
Progesterone .0.3 ng/ml No Yes Yes
Display oestrus No No Yes
Mean FSH (ng/ml+ SEM) 11.8+0.2a 10.2+1.0a 5.4+1.3b
Mean LH (ng/ml+ SEM) 2.6+0.2a 2.5+0.2a 1.4+0.2b
Mean AMH (ng/ml+ SEM) 4.8+1.7a 21.9+6.9b 26.0+7.4b
Ovarian tissue section area (Mean+ SEM; mm2) 47.0+14.7a 62.1+15.3a 172.1+0.24b
Pretreatment (time 0) primordial and pre-antral follicle density (Follicles/mm3)* 3.09+0.57a 3.68+0.84a 2.48+0.98a
Post-treatment primordial and pre-antral follicle density (follicles/mm3)* 0.64+0.21a 0.70+0.27a 1.43+0.10b
Aspirin was administered either pre-operatively only or both pre-operatively and post-operatively. Data have been analysed on the basis of sheep which showed no, partial or full
restoration of ovarian function within 3 months of autotransplantation of cryopreserved ovaries. Different superscripts indicate signiﬁcant differences within rows (P, 0.05).
*Values subject to square root (+0.5) transformation prior to analysis.
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different initial primordial follicle density derived fromTime0 controls on
subsequent restoration of ovarian function also showed no apparent re-
lationship, as the ewes which showed full restoration had the lowest
overall follicle counts (Table I).Overall, the results of Study1 represented
a signiﬁcant advance in the success ofWOCP&TP by demonstrating that
the incorporation of a pre-operative treatment with anti-thrombotic
aspirin was able to restore full ovarian function in around a quarter of
the animals that underwent WOCP&TP within 4–7 weeks of surgery.
However, the rateof restorationofovarian function (25%)andtherelative-
ly lowrateofprimordial follicle survival in cyclinganimals (29%)were still far
below the levels needed for this technique to be adopted as a clinical inter-
vention. An additional series of in vitro experiments were therefore
Figure 2 Results from the 2010–2011WOCP&TP study (Study 1). (A) Hormone proﬁles from a single ewe (Ewe 22) who showed full restoration of
ovarian function following WOCP&TP. Note the rapid decline in circulating FSH to normal levels within 14 days of autotransplantation, with ovulation
occurring after 21 days, as evidenced by the initiation of a series of cyclic ﬂuctuations in progesterone indicative of regular estrous cycles. Red bars indicate
times at which oestrus activity was observed in this ewe. (B) Histological appearance of cryopreserved ovary (Ov) with an early cycle corpus luteum (CL)
andmorphologically normal vascular pedicle (VP)3months after autotransplantation.Theblue5/0Prolene suturesused toattach theovarianpedicle to the
uterine wall can be clearly seen. (C) Histological section through an ovary shown in (B) illustrating normal appearance and vascularity of ovarian structures
with a normal corpus luteum (CL) and a healthy large antral follicle (AF) evident in the section. Scale bar 500 mm.
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undertaken to further optimize theWOCP protocol and assess the pos-
sibility that CPA toxicity may explain the relatively high rate of loss of
ovarian follicles followingWOCP&TP.
Determination of the effect of time of CPA
infusion on CPA penetration and toxicity
Theprimary challengeoforgancryopreservation is thenecessity tomain-
tain the functionality of multiple cell types within the organ whilst main-
taining the integrity of the vascular supply post freeze-thaw. To address
this question, we initially determined the relationship between the
period of CPA perfusion of the ovarian pedicle and the degree of CPA
penetration into the ovarian cortex, in which the primordial follicles
are located. These data, determined by NMR spectrophoretic analysis
(Fig. 3A), revealed a linear relationship (r ¼ 0.98; P, 0.001) between
0–60 min of perfusion with CPA uptake of 100% after 60 min. We
therefore set out to determine whether shorter periods of CPA expos-
ure could limit damage to the ovarian vascular tissue due to CPA toxicity
whilstmaintaining penetration and cryoprotection of the ovarian cortex.
Release of the enzyme LDH during overnight incubation of frozen/
thawed tissue isolated from the ovarian cortex, medulla and vascular
pedicle was used as an index of cryodamage and CPA toxicity. The
data indicate that WOCP without CPA (0 perfusion time) resulted in
the highest level of LDH release for all tissues, thus reﬂecting substantial
cryodamage (Fig. 3). There were, however, marked differences in the
relationship between LDH release and period of CPA exposure
between the ovarian cortex and the vascular ovarian medulla and
pedicle (Fig. 3b; P, 0.001).
Within the ovarian cortex, the lowest level of LDH release, and
therefore cellular damage, was detected following the shortest periods
of CPA perfusion (3 and 10 min), with higher levels at 15 and 30 min
(P, 0.05) and with 60 min (our standard perfusion time) being in-
termediate between these two extremes. This result suggested that
the 60 min period of CPA perfusion that had been used during
WOCP&TP may have been resulting in CPA-induced cytotoxic
damage to the ovarian cortex. This hypothesis was supported by the
NMR analysis which showed very high rates of CPA uptake by the
ovarian cortex at this infusion period (Fig. 3A). In contrast to the
ovarian cortex, LDH release by the more vascular tissue of the ovarian
medulla and pedicle did not differ signiﬁcantly between CPA perfusion
times of 3–60 min, apart from an increase at 15 min perfusion in the
ovarian pedicle (Fig. 3B). This suggested that in vascular tissue, cryodam-
age due to lackofCPAexposuremaybe balancedbyCPA toxicity result-
ing from the rapidity of CPA penetration. It therefore appeared unlikely
that we would be able limit CPA toxicity to vascular tissue by reducing
perfusion times.
Figure 3 Graphs showing CPA penetration in the ovarian cortex (A) and the effect of CPA perfusion time (B) on the production of LDH (as an index of
tissue damage) by ovarian cortex, medulla and pedicle. Values are mean+ SEM. Different letters indicate statistically signiﬁcant differences at P, 0.05.
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Overall, the results of these in vitrooptimization studies demonstrated
that although the 60 min perfusion time afforded sufﬁcient cryoprotection
to both the ovarian cortex and the cortex-medullar interface tomaintain
the small antral follicle population following WOCP, shorter periods of
CPA perfusion may be advantageous in terms of limiting potential CPA
toxicity in the cortex whilst maintaining adequate cryoprotective cover
in the ovarian vasculature.
Study 2 (2011–2012): the effect of timeofCPA
perfusion and post-operative anti-thrombotic
therapy on the success ofWOCP&TP in vivo
On the basis of results obtained both Study 1 and from the in vitro studies
described above, a second study, which was conducted over 2011–
2012, tested whether a 10 or 60 min CPA perfusion supported superior
restoration of ovarian function following WOCP&TP and whether an
extended post-operative regime of anti-thrombotic agents would reduce
post-transplant ischaemia by preventing clot formation in the ovarian vas-
culature inducedby cryo- and cyto-toxic damage to the arterial endothe-
lial cells (Onions et al., 2013). The two regimes tested, as stated above,
combined pre- and post-operative aspirin treatment with either the in-
jectable low molecular weight heparin enoxaparin (Asp+LMWH) or
the glycoprotein IIb/IIIa inhibitor eptiﬁbatide (Asp+Eptiﬁb).
The results of this study were far beyond expectation in terms of the
consistency of the response. Apart from two animals removed from the
analysis due to procedural errors, all remaining animals (14/14) showed
restoration of ovarian function with subsequent ovulation within 2–3
weeks of surgery (Fig. 4A). As further conﬁrmation of the full restoration
of ovarian function, over the subsequent 3month periodwhen the ewes
were run with an entire ram, 9/14 (64%) became pregnant (Fig. 5A;
Table II) and 4/14 ewes maintained these pregnancies to term, with
the birth of a total of seven normal lambs (Figs 5 and 6A; Table II). Sub-
sequent development of these offspring has been normal and one of the
females has gone on to establish a normal pregnancy to term with the
birth of a normal male lamb. Those ewes that aborted did so mainly
during the transition from the second to the third trimester (97+5.1
days, gestation 142–144 days in sheep; Fig. 5C). Those animals that
did not get pregnant displayed either regular oestrous cycles (Fig. 5B)
until the end of the breeding season or did not cycle and showed
persistently high progesterone values for around 90–140 days
(Fig. 5D), consistent with maintenance of luteal function due to perturb-
ation of luteal regression mechanisms (Goding et al., 1972), resulting
from the anatomical changes made as part of the transplant procedure.
Recovery of ovarian tissue either 8 or 22 months after WOCP&TP
from all animals showed clear evidence of a superior outcome in
ovaries that had been perfused with CPA for the longer 60 min period.
In all instances, the 60 min perfusion resulted in an ovary of normal
appearance containing numerous primordial, pre-antral and antral folli-
cles (Table III) with an apparently normal ovarian vascular pedicle with
an abundant ovarian blood supply evident on Doppler ultrasound
(Fig. 6B–D). In addition, in the four animals that carried live births to
term and were sacriﬁced in the breeding season, all had corpora lutea
present in the ovary perfused with CPA for 60 min. In contrast,
ovaries perfused with CPA for the shorter 10 min period had either
been resorbed completely and were vestigial (6/10; Fig. 6C) or were
markedly smaller (P ¼ 0.002) than the contralateral ovary in the same
animal that had been perfused for 60 min (Table III). These smaller
ovaries contained fewer pre-antral (P ¼ 0.01) and antral (P ¼ 0.02)
follicles (Table III) and also had lower levels of blood ﬂow evident from
Doppler ultrasound (Fig. 6C) despite the ovarian vascular pedicle
appearing to be macroscopically normal and patent. Overall, these
results demonstrated clearly that the period of exposure to CPA is a
key determinant of the success of the WOCP&TP procedure and that
the60 minperfusionperiodwas superior for thepreservationof function
in whole adult sheep ovaries.
Comparison between the efﬁcacy of the two anti-coagulant regimes
tested in this experiment revealed no difference in terms of either the
proportion of ewes that resumed ovarian function, became pregnant
or carried lambs to term (Fig. 4A; Table II). Examination of the effects
of the anti-coagulant therapy within different CPA perfusion times
showed no signiﬁcant effect on ovarian size, primordial and pre-antral
or antral follicle number (data not shown). Based on the Time 0 primor-
dial and pre-antral follicle density determined from a similar group of
animals in Study 1 (12.4+3.8 follicles/mm3; non-transformed data),
we estimate that 60–70% of the primordial follicles survived the
WOCP&TP procedure in ovaries perfused with CPA for 60 min, al-
though there was signiﬁcant between-animal variation. The lack of
effect of anti-coagulant on follicle survival was generally consistent with
analysis of endocrine markers of ovarian reserve evident between
these two treatment groups. As shown in Fig. 4B, all ewes exhibited an
acute decline in FSH levels followingWOCP&TP which could be attrib-
uted to continued growth and development of the growing follicle popu-
lation. Ewes treated with Asp+LMWH(Hep) exhibited a more acute
decline in FSH (13.8+2.2 days) than those treated with Asp+
Eptiﬁb(Integ) (27.7+3.1 days; P ¼ 0.003) and returned to normal
levels within 5–6 weeks of TP. In contrast, ewes treated with Asp+
Eptiﬁb(Integ) took 7 weeks to reach a nadir of around 3.5 ng/ml
before increasing again to a peak of 8.7 ng/ml at 12 weeks and declining
thereafter to normal levels towards the end of the experimental period.
As a result of this bimodal pattern of secretion, FSH levels were signiﬁ-
cantly higher (P ¼ 0.03) in Asp+Eptiﬁb treated ewes for 3 months
after aTP but did not differ thereafter. As expected, mean LH values
exhibited a similar decline following TP as was observed with FSH but
overall LH values did not differ signiﬁcantlywith anti-coagulant treatment
(Fig. 4C). As expected, both AMH and inhibin A levels increased signiﬁ-
cantly (P, 0.01) over the initial 3–4 months after aTP and then
remained relatively stable thereafter (data not shown). There were no
signiﬁcant differences in the patterns of AMH or inhibin A levels post-
transplantation in ewes which received the different anti-thrombotic
regimes (Table II).
Discussion
Although a single livebirth has previously been reported fromoneof nine
lambs that had undergoneWOCP&TP (Imhof et al., 2006), this paper is
the ﬁrst to report high rates of acute restoration of ovarian function and
fertility in large animals with multiple live births following cryopreserva-
tion and aTP of whole adult ovaries. As far as we are aware this work
also represents the ﬁrst report of full restorationof functionality following
freezing of any adult organ from a large mammal.
This breakthrough has been achieved through optimization of freezing
and thawing protocols whichmaximize cryoprotectionwhilst minimizing
cytotoxicity during cryopreservation and by utilizing anti-thrombotic
agents post-operatively to prevent post-operative ischaemia in the
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Figure4 WOCP&TPexperiment in 2011–2012 (Study2);Mean+ SEMprogesterone (A), FSH (B) andLH(C) concentrations in jugular venousplasma
over the 8months following autotransplantationof cryopreservedovaries. Closed symbols illustrate hormone levels in eweswhich received post-operative
treatment with an anti-coagulant regime consisting of Asp+Hep (LMWH) (n ¼ 7) whereas open symbols show data for ewes treated with Asp+Integ
(Eptiﬁb) (n ¼ 7). From approximately Day 180, data from pregnant animals were no longer included in the proﬁles so n ¼ 5/group for these proﬁles.
Note the rapid restoration of ovarian function as evident from the rapid fall in peripheral FSH and LH concentrations following autotransplantation and
rapid increase in progesterone after 14–21 days, indicating ovulation within 2–3 weeks of transplantation. Note also the difference in FSH proﬁles
between anti-coagulant regimes reﬂecting a higher degree of efﬁcacy for Asp+Hep at this dose.
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cryopreserved organdue to clot formation in the organ vasculature result-
ing from endothelial cell cryodamage and cytotoxicity. These innovations
provide valuable insights into how whole organ preservation and trans-
plantation could be used to preserve and restore fertility in girls and
women at risk of POF. They also provide proof of principle for potential
applications involving the cryopreservation of other human organs.
The successful application of WOCP&TP to mature adult animals in
these studies reinforces the potential advantages of WOCP&TP over
the alternate intervention of ovarian cortex autografting. By preserving
the entire ovarian reservewithin thewhole ovary andminimizing primor-
dial follicle loss due to post-operative ischaemia by acute restoration of
blood ﬂow to the transplant by vascular anastomosis, we have achieved
acute restoration of ovarian function and fertility without signiﬁcant
endocrine disturbance and importantly have incurred very low rates of
primordial follicle loss compared with the levels incurred during cortex
autografting (Baird et al., 1999). The surviving follicle population of
Figure 5 WOCP&TP experiment in 2011–2012 (Study 2); Progesterone proﬁles from individual ewes illustrating different reproductive outcomes fol-
lowing WOCP&TP. (A and C) Two animals (Ewes 19 and 28) who became pregnant after showing two spontaneous oestrous cycles with Ewe 19 (A)
successfully giving birth to a normal lamb after a normal gestation of 140 days and Ewe 28 aborting in the third trimester (Day 106). (B and D) Two
ewes who did not become pregnant. Ewe 25 (B) ovulated within 2 weeks of autotransplantation and had regular oestrous cycles until the beginning of sea-
sonal anoestrus in this species (light greybaron x-axis of ﬁgure). It is likely thatpregnancywasprevented in this animal due toeither damage to theoviductsor
mislocation of the ovary. Ewes 23 (D) also ovulated rapidly after autotransplantation but did not cycle with high progesterone being maintained for 140
days. Post-mortemconﬁrmed that this animal had a fully functional ovaryand it is therefore likely that the surgeryhad interferedwith thenormalmechanisms
regulating luteal regression in this species.
.............................................................................................................................................................................................
Table II Summaryof results fromWOCP1TPstudyconducted in2011–2012 (Study2) showing reproductiveperformance
of ewes treatedwith two different anti-coagulant regimeswhich consisted of Aspirin and LMWH(Asp1LMWH) orAspirin
and Eptiﬁbatide (Asp2Eptiﬁb).
Characteristic Asp1LMWH (n5 7) Asp1Eptiﬁb (n5 7) Total/P
Proportion ovulated (%) (progesterone .1 ng/ml 14 days) 7/7 (100) 7/7 (100) 14/14 (100)
Proportion showed oestrus (%) 6/7 (86) 6/7 (86) 12/14 (86)
Proportion became pregnant (%) 5/7 (71) 4/7 (57) 9/14 (64)
Proportion lambed (no/sex lambs) (%) 2/7 (3C, 1F) 2/7 (1C, 2F) 4/14 (29)
AMH (ng/ml)a 32.5+7.1 47.2+18.1 1.0
Inhibin A (ng/ml)a 0.43+0.06 0.48+0.07 0.20
Of the 16 ewes treated, one from each group was removed from the analysis due to methodological errors during the surgery (see methods for more detail).
aDetermined 5 months after autotransplantation.
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30–40 000, estimated in ovaries perfused with CPA for 60 min from
animals treated with aspirin+LMWH, would be expected to be sufﬁ-
cient to restore ovarian function and fertility in a human context for
many decades (Wallace and Kelsey, 2010). Indeed higher rates of follicle
survival (.70%) should be achievable with further procedural optimiza-
tion. While it is true that the period of restoration of fertility following
autografting of ovarian cortex in humans (around 5 years; Silber, 2012;
Donnez et al., 2013) has been longer than that demonstrated in earlier
sheep studies (2 years; Baird et al., 1999), it is clear that cortex auto-
grafting is most effective in younger women with higher ovarian
reserves (Donnez et al., 2013). Given the greater surgical complexity,
the all-or-none nature of the intervention and the greater risk of
re-introduction of malignant tissue in cancer survivors, WOCP&TP,
when compared with cortex autografting, may therefore prove most
valuable as an alternative treatment in olderwomenwhere autografting
of fragments of the cortex is unlikely to be as successful or conversely
in young girls where the ability to restore full reproductive longevity
would be advantageous. However, in order to make these options a
Figure6 WOCP&TPexperiment in 2011–2012 (Study 2). (A) Imageof 2 of the 4Greyface ewes that becamepregnant followingWOCP&TPwith their
lambs (1 singleton and 1 set of triplets). (B) Normal appearance of ovary (O) and vascular pedicle (VP) in a ewe 10 months afterWOCP&TP. Right hand
insert is conventional ultrasound image showingpresenceof numerous large antral follicles in theovary. Left hand inset showsDoppler ultrasound illustrating
high levels vascular perfusion. (C) Illustration of the effect of different CPAperfusion time on subsequent ovarian function. The left ovary (upper circle) was
perfusedwithCPA for 60min and right ovary (lower circle)wasperfused for 10 min prior toWOCP&TP in same animal. The left ovary appears normal, has
well vascularized pedicle (VP) and as shown by left inset has numerous large follicles. The right ovary, despite good post-operative perfusion, was vestigial
with few follicles and lowbloodﬂow(right inset) 8months afterWOCP&TP. (D)Histological image showing aclusterof numerousprimordial follicleswithin
an ovary recovered 8 months afterWOCP&TP. It is estimated that 70% of primordial follicles survived this procedure and as this represents tens of thou-
sands of follicles, this follicular cohort would enable restoration of ovarian function for several decades. Scale bar 39 mm.
........................................................................................
Table III Summary of results fromWOCP1TP study
conducted in 2011–2012 (Study 2) showing the effect of
CPA perfusion times on the ovarian size and density of
ovarian follicles in paired ovaries from each ewe
perfused with CPA for either 10 or 60 min prior to
cryopreservation.
Characteristic 10 min
(n5 14)
60 min
(n 5 14)
P
Ovarian area section (mm2) 113+22 274+25 0.0002
Primordial and pre-antral
follicledensity (follicles/mm3)
1.73+0.27 2.45+0.37 0.013
Antral follicle density
(follicles/mm3)
0.87+0.08 1.04+0.05 0.021
Follicle density values have been subject to square root (+0.5) transformation prior to
analysis and presentation. Data have been pooled across anti-coagulant regimes as
there were no signiﬁcant differences between groups.
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reality, further optimization with animal experimentation is required
(see below).
The importance of optimizing exposure time toCPA in order to allow
adequatepenetrationofCPA,whilstminimizingCPA toxicity,was clearly
illustrated in this study by the difference in ovarian function observed
between ovaries infused with CPA for either 10 or 60 min prior to
WOCP. Despite in vitro results indicating less tissue damage in ovaries
perfused for the shorter time period (Fig. 4B), the longer time period
was markedly superior following aTP in vivo, presumably because of
the much higher degree of CPA penetration achieved to the ovarian
cortex after 60 min of perfusion (Fig. 4A). The extremely rapid restor-
ation of ovarian function achieved following WOCP&TP in some ewes
in Study 1 and in all ewes in Study 2 (2–3 weeks) is consistent with
results from follicle dissection and culture experiments showing that
the 60 min WOCP protocol does not adversely affect the viability
of gonadotrophin-responsive follicles up to the small antral stage
(1–2.3 mm indiameter; VOnions andBKCampbell, unpublishedobser-
vations). Although we can conclude that this period of CPA exposure
is optimal forWOCPof adult sheep ovaries, the application of this tech-
nology to girls and adult women, in which the ovaries are smaller and
larger respectively, would require further optimization utilizing other
animal model ovaries of an appropriate size (e.g. lambs, cows) and/or
donated human ovaries. Despite there being a number of reports of
high rates of post-thaw tissue viability in a small number of donated
human ovaries processed for WOCP in the literature (Bedaiwy et al.,
2006; Jadoul et al., 2007; Martinez-Madrid and Donnez, 2007), in our
experience acute in vitro estimates of post-thaw viability are poor predic-
tors of long-term ovarian function in vivo followingWOCP&TP (Onions
et al., 2008, 2009). Thus the results of the present studies emphasizes the
need to fully optimize the cryopreservation protocol for each type of
ovary before attempting aTP.
The other major intervention which was critical to the success of
the WOCP&TP procedure was the pre- and post-operative use of
anti-thrombotics to prevent acute clot formation in the frozen-thawed
vasculature of the cryopreserved organ. The rationale for their usewas
based on our previous observations that (i) high rates of follicle loss
were often observed following WOCP&TP despite long-term main-
tenance of ovarian vascular supply (Onions et al., 2008, 2009) and
that (ii) clot formation in the ovarian vasculature occurred acutely
following WOCP&TP and this was associated with up-regulation of
endothelial gene expression of factors associated with vascular
tone and apoptosis (Onions et al., 2013). The critical nature of this
intervention to the success of the procedure is clearly illustrated
by comparing the results of Study 1 (2010–2011) WOCP&TP
experimentwith that of Study 2 (2011–2012). Both these experiments
utilized the 60 min perfusion period, but in 2010–2011, where ewes
were treated with aspirin alone, only 4/15 (27%) displayed restoration
of ovarian function and in those animals follicle survival was low (20%).
In contrast, in Study 2 (2011–2012) where animals were treated with a
combination of aspirin and enoxaparine (Clexanew) or eptiﬁbatide
(Integrilinw), all animals showed restoration of ovarian function and
follicle survival was much higher (60–70%). The use of an optimized
anti-thrombotic regime is therefore critical to the success of this
procedure.Of the two anti-thrombotics tested in 2011–2012, although
there was no difference between the regimes in terms of the rate of
restoration of ovarian function and fertility, the Asp+LMWH regime
appeared marginally superior to the Asp+Eptiﬁb in terms of follicle
survival, as evidenced by both direct ovarian counts (Table II) and differ-
ences in FSH levels (Fig. 4). However, this result needs to be treatedwith
some caution as the doses of both these drugs require optimization for
this application. Further experimentation is therefore required to deter-
minewhethermore aggressive anti-thrombotic regimes, involving longer
periods of post-operative treatment and/or higher doses, would have a
further beneﬁcial effect on primordial follicle survival following
WOCP&TP.
Although these studies indicate that WOCP&TP may be a viable
clinical intervention for restoration of fertility in women, there are a
number of concerns that need to be addressed before the clinical
application of this technology. The ﬁrst of these concerns is the fact
that although all animals had functioning ovaries, a number of the
animals did not show regular oestrous cycles and/or did not get
pregnant despite displaying regular cycles. Both of these effects can
be attributed to the degree of the surgical intervention required to
perform the double ovarian autotransplant. Luteal regression in
sheep, unlike the human, is regulated by the release of prostaglandin
F2a (PGF2a) from the non-pregnant uteruswhich passes by a counter-
current mechanism from the utero-ovarian vein to the ovarian artery
(McCracken et al., 1972). In Study 2, it was necessary to anastomose
the ovarian artery directly to the uterine artery and it is therefore
likely that this surgical intervention resulted in perturbation of this
luteolytic signal transfer mechanism and hence long-termmaintenance
of the corpus luteum that resulted from the ﬁrst ovulation after aTP in
some animals (Fig. 5D). Similarly, in animals which cycled regularly but
did not get pregnant (Fig. 5B), it is likely that the positioning of the trans-
planted ovary and/or post-operative adhesions had prevented oocyte
pick-up by the oviduct and this was conﬁrmed at the time of post-
mortem. In a clinical context, these complications could therefore be
minimized by a less radical surgical intervention in which normally
only one frozen ovary would be autotransplanted to an optimal site
for both reanastomosis of the ovarian vasculature and maintenance
of oviduct function. Further, it is well established that, unlike the luteo-
lyticmechanism controllingmaintenanceof the corpus luteum in sheep,
a luteotrophic mechanism mediated by the release of hCG from
the developing conceptus operates in primates (Bazer et al., 2010). It
therefore appears unlikely that either of these complications would
have a major impact in the clinical application of this intervention
although importantly, fertility restoration in women following
WOCP&TP need not be totally reliant on the success of natural
ovulation as it can be supported through the use of established assisted
reproduction interventions.
In conclusion, the results of this studydemonstrate that full restoration
of ovarian function and high rates of fertility can be obtained following
WOCP&TPbyoptimizationofCPApenetrationduringwholeovaryper-
fusion along with the use of anti-thrombotic agents to prevent post-
operative clot formation in the ovarian vasculature. It is hoped that this
work represents a major advance toward the possible development
and clinical application of WOCP&TP as a means to preserve and
restore the fertility of girls and women at risk of POF. However, before
WOCP&TP can be used clinically, further animal model studies are
required to (i) develop optimized cryopreservation protocols for a range
of different sized ovaries similar to those observed in prepubertal girls,
adolescents and mature women and (ii) generate more information on
the optimal type, dose and duration of post-operative anti-thrombotic
therapy.
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